Benefit of combination &beta;-blocker and endoscopic treatment to prevent variceal rebleeding: A meta-analysis

doi:10.3748/wjg.v16.i47.5982

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 47

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2812)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-6) series.

Item

Count

PDF

468

HTML

1934

Figures (1-1)

197

Tables (1-6)

213

Sum=2812

Dec 21, 2010 (publication date) through Nov 30, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Dec 21, 2010; 16(47): 5982-5992
Published online Dec 21, 2010. doi: 10.3748/wjg.v16.i47.5982

Open in New Tab Full Size Figure Download Figure

Figure 1 Meta-analysis for rebleeding at 12 mo (A), overall rebleeding (B), overall mortality (C) and mortality at 24 mo (D) for trials comparing combined endoscopic treatment (sclerotherapy or banding ligation) and β-blockers with endoscopic treatment alone. SCL: Sclerotherapy: BL: Banding ligation; BB: β-blockers; OR: Odds ratio; CI: Confidence interval.

Citation: Funakoshi N, Ségalas-Largey F, Duny Y, Oberti F, Valats JC, Bismuth M, Daurès JP, Blanc P. Benefit of combination β-blocker and endoscopic treatment to prevent variceal rebleeding: A meta-analysis. World J Gastroenterol 2010; 16(47): 5982-5992
URL: https://www.wjgnet.com/1007-9327/full/v16/i47/5982.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i47.5982